ABSTRACT Lung cancer is a malignant tumor of the lung originating from the bronchial mucosa, glands or alveolar epithelium. With the population aging and environmental pollution getting increasingly severe, lung cancer has become the malignant tumor with the highest incidence and mortality rate in China, seriously endangering people's life and health. However, there is no standardized guideline for the integrated Chinese and Western medicine treatment of lung cancer in China. In order to standardize and improve integrated Chinese and Western medicine diagnosis and treatment of lung cancer in China, the First Affiliated Hospital of Guangzhou University of Chinese Medicine, together with oncologists from the Sun Yat-sen University Cancer Center, compiled this consensus under the coordination of the Medical Policy Department of the National Administration of Traditional Chinese Medicine, taking into account the main results of the pilot project of Chinese and Western Medicine Clinical Collaboration for Major Difficult Diseases (lung cancer).
LIN et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: